Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.
Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo.
复制标题
小檗碱基于体外和体内荧光药代动力学逆转乳腺癌多药耐药性
DOI:
10.1021/acsomega.0c06288
复制
发表时间:
2021-04-27
期刊:
影响因子:
4.1
通讯作者:
Xiong Y
中科院分区:
文献类型:
--
作者:
Qian K;Tang CY;Chen LY;Zheng S;Zhao Y;Ma LS;Xu L;Fan LH;Yu JD;Tan HS;Sun YL;Shen LL;Lu Y;Liu Q;Liu Y;Xiong Y
Exploring the mechanism through which berberine (Ber) reverses the multidrug resistance (MDR) of breast cancer is of great importance. Herein, we used the methyl thiazolyl tetrazolium assay to determine the drug resistance and cytotoxicity of Ber and doxorubicin (DOX) alone or in combination on the breast cancer cell line MCF-7/DOXFluc. The results showed that Ber could synergistically enhance the inhibitory effect of DOX on tumor cell proliferation in vitro, and the optimal combination ratio was Ber/DOX = 2:1. Using a luciferase reporter assay system combined with the bioluminescence imaging technology, the efflux kinetics of d-luciferin potassium salt in MCF-7/DOXFluc cells treated with Ber in vivo was investigated. The results showed that Ber could significantly reduce the efflux of d-luciferin potassium salt in MCF-7/DOXFluc cells. In addition, western blot and immunohistochemistry experiments showed that the expression of P-glycoprotein (P-gp/ABCB1) and multidrug resistance protein 1 (MRP1/ABCC1) in MCF-7/DOXFluc cells was downregulated upon Ber treatment. Finally, high-performance liquid chromatography was used to investigate the effect of Ber on DOX tissue distribution in vivo, and the results showed that the uptake of DOX in tumor tissues increased significantly when combined with Ber (P < 0.05). Thus, the results illustrated that Ber can reverse MDR by inhibiting the efflux function of ATP-binding cassette transporters and downregulating their expression levels.
登录
查看更多内容
影响因子:
4.6
作者:
Bekele RT;Venkatraman G;Liu RZ;Tang X;Mi S;Benesch MG;Mackey JR;Godbout R;Curtis JM;McMullen TP;Brindley DN
通讯作者:
Brindley DN
影响因子:
5.2
作者:
Barbuti AM;Chen ZS
通讯作者:
Chen ZS
影响因子:
--
作者:
Liu S;Chen S;Yuan W;Wang H;Chen K;Li D;Li D
通讯作者:
Li D
影响因子:
3.6
作者:
Hermanson, David L.;Das, Sonia G.;Xing, Chengguo
通讯作者:
Xing, Chengguo
影响因子:
7.5
作者:
Scarfe L;Taylor A;Sharkey J;Harwood R;Barrow M;Comenge J;Beeken L;Astley C;Santeramo I;Hutchinson C;Ressel L;Smythe J;Austin E;Levy R;Rosseinsky MJ;Adams DJ;Poptani H;Park BK;Murray P;Wilm B
通讯作者:
Wilm B